Weyer Christian
Insider CIK 1493811 · ICPT EVP, Research & Development · FATE See remarks, Director · AMLN SVP, Research & Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-04-01 | 2021-04-05 | 46 | $24.28 | $1.1K | 27,341 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-02-27 | 2021-03-02 | 357 | $21.66 | $7.7K | 27,387 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2021-01-22 | 2021-01-26 | 19,700 | — | $0 | 19,700 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-01-22 | 2021-01-26 | 12,600 | — | $0 | 27,744 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-01-01 | 2021-01-05 | 54 | $24.70 | $1.3K | 15,144 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-12-31 | 2021-01-05 | 779 | $24.70 | $19.2K | 15,198 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-11-27 | 2020-11-30 | 357 | $37.27 | $13.3K | 15,977 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-10-01 | 2020-10-05 | 46 | $42.08 | $1.9K | 16,334 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-08-27 | 2020-08-31 | 357 | $48.81 | $17.4K | 16,380 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-07-01 | 2020-07-06 | 46 | $46.52 | $2.1K | 16,737 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-05-27 | 2020-05-29 | 357 | $74.43 | $26.6K | 16,783 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2020-04-27 | 2020-04-29 | 181 | $85.95 | $15.6K | 17,140 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-04-01 | 2020-04-03 | 46 | $58.40 | $2.7K | 17,321 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2020-02-27 | 2020-02-28 | 113 | $87.62 | $9.9K | 17,367 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-02-27 | 2020-02-28 | 357 | $85.39 | $30.5K | 17,480 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2020-01-27 | 2020-01-27 | 723 | $94.04 | $68.0K | 17,837 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2020-01-23 | 2020-01-27 | 7,900 | — | $0 | 7,900 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2020-01-23 | 2020-01-27 | 4,800 | — | $0 | 18,560 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-01-01 | 2020-01-03 | 54 | $123.92 | $6.7K | 13,760 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-12-31 | 2020-01-03 | 364 | $123.92 | $45.1K | 13,814 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-12-27 | 2019-12-30 | 54 | — | $0 | 2,883 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-12-27 | 2019-12-30 | 416 | — | $0 | 17,692 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-12-27 | 2019-12-30 | 1,581 | $123.24 | $194.8K | 14,178 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-12-27 | 2019-12-30 | 416 | $59.12 | $24.6K | 15,705 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-12-27 | 2019-12-30 | 54 | $58.74 | $3.2K | 15,759 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-11-27 | 2019-12-02 | 875 | — | $0 | 18,108 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-11-27 | 2019-12-02 | 52 | — | $0 | 2,937 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-11-27 | 2019-12-02 | 875 | $59.12 | $51.7K | 16,634 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-11-27 | 2019-12-02 | 357 | $109.16 | $39.0K | 15,289 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-11-27 | 2019-12-02 | 52 | $58.74 | $3.1K | 16,686 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-11-27 | 2019-12-02 | 1,040 | $101.65 | $105.7K | 15,646 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-11-26 | 2019-11-27 | 4,267 | — | $0 | 18,983 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-11-26 | 2019-11-27 | 106 | — | $0 | 2,989 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-11-26 | 2019-11-27 | 4,373 | $100.00 | $437.3K | 15,759 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-11-26 | 2019-11-27 | 4,267 | $59.12 | $252.3K | 20,026 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-11-26 | 2019-11-27 | 106 | $58.74 | $6.2K | 20,132 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-11-25 | 2019-11-27 | 1,750 | — | $0 | 23,250 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-11-25 | 2019-11-27 | 105 | — | $0 | 3,095 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-11-25 | 2019-11-27 | 1,750 | $59.12 | $103.5K | 17,509 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-11-25 | 2019-11-27 | 105 | $58.74 | $6.2K | 17,614 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-11-25 | 2019-11-27 | 1,855 | $100.00 | $185.5K | 15,759 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-11-19 | 2019-11-19 | 1,550 | $85.00 | $131.8K | 15,759 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-11-13 | 2019-11-15 | 946 | $85.00 | $80.4K | 17,309 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-10-01 | 2019-10-03 | 46 | $65.87 | $3.0K | 18,255 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-08-27 | 2019-08-29 | 357 | $60.50 | $21.6K | 18,301 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-07-01 | 2019-07-03 | 46 | $79.17 | $3.6K | 18,658 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-05-27 | 2019-05-29 | 357 | $87.83 | $31.4K | 18,704 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-04-01 | 2019-04-03 | 46 | $111.50 | $5.1K | 19,061 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-03-01 | 2019-03-01 | 333 | $103.16 | $34.4K | 19,107 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-02-27 | 2019-03-01 | 364 | $92.76 | $33.8K | 19,440 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2019-01-16 | 2019-01-18 | 6,800 | — | $0 | 6,800 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2019-01-16 | 2019-01-18 | 4,200 | — | $0 | 19,804 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-01-01 | 2019-01-03 | 215 | $100.79 | $21.7K | 15,604 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2018-11-29 | 2018-11-29 | 1,343 | $113.78 | $152.8K | 15,819 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2018-11-27 | 2018-11-29 | 1,438 | $108.66 | $156.3K | 17,162 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2018-02-05 | 2018-02-22 | 3,200 | — | $0 | 3,200 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2018-02-05 | 2018-02-22 | 2,100 | — | $0 | 18,600 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2017-11-27 | 2017-12-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2017-11-27 | 2017-12-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise deriv | 2015-04-13 | 2015-04-14 | 25,000 | — | $0 | 258,040 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise | 2015-04-13 | 2015-04-14 | 25,000 | $1.37 | $34.3K | 30,429 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2015-01-05 | 2015-01-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2015-01-05 | 2015-01-07 | 5,429 | — | $0 | 5,429 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise deriv | 2014-04-02 | 2014-04-03 | 2,262 | — | $0 | 283,040 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise | 2014-04-02 | 2014-04-03 | 2,262 | $1.37 | $3.1K | 2,262 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2014-04-02 | 2014-04-03 | 2,262 | $9.02 | $20.4K | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise deriv | 2014-04-01 | 2014-04-03 | 7,738 | — | $0 | 285,302 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise | 2014-04-01 | 2014-04-03 | 7,738 | $1.37 | $10.6K | 7,738 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2014-04-01 | 2014-04-03 | 7,738 | $9.02 | $69.8K | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2014-01-09 | 2014-01-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 1,208 | $31.00 | $37.4K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 6,252 | $31.00 | $193.8K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 11,973 | $31.00 | $371.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 6,242 | $31.00 | $193.5K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 2,633 | $31.00 | $81.6K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 7,360 | $31.00 | $228.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 35,000 | $31.00 | $1.08M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 937 | $31.00 | $29.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 3,973 | $31.00 | $123.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 1,484 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 14,320 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 12,516 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 16,027 | $31.00 | $496.8K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 144 | $31.00 | $4.5K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 833 | $31.00 | $25.8K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 19,340 | $31.00 | $599.5K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 2,930 | $31.00 | $90.8K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 123,758 | $31.00 | $3.84M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 113,027 | $31.00 | $3.50M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 13,748 | $31.00 | $426.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 3,680 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 1,012 | $31.00 | $31.4K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 33,195 | $31.00 | $1.03M | 1,012 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 453 | $31.00 | $14.0K | 886 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 886 | $31.00 | $27.5K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 359 | $31.00 | $11.1K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 4,815 | $31.00 | $149.3K | 3,159 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 3,159 | $31.00 | $97.9K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-07-25 | 2012-07-26 | 39 | $14.62 | $570 | 34,207 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award deriv | 2012-03-06 | 2012-03-07 | 123,758 | — | $0 | 123,758 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award deriv | 2012-03-06 | 2012-03-07 | 6,242 | — | $0 | 6,242 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-03-06 | 2012-03-07 | 1,529 | — | $0 | 7,974 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-03-06 | 2012-03-07 | 10,000 | — | $0 | 34,168 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | S Sale | 2012-03-01 | 2012-03-02 | 1,231 | $17.11 | $21.1K | 24,168 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | S Sale | 2012-02-23 | 2012-02-24 | 2,519 | $17.03 | $42.9K | 24,597 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-02-22 | 2012-02-24 | 6,700 | — | $0 | 27,116 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-02-08 | 2012-02-10 | 10,000 | — | $0 | 24,259 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | S Sale | 2012-02-08 | 2012-02-10 | 3,843 | $16.62 | $63.9K | 20,416 | SEC↗ |